US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 20.310
  • -0.500-2.40%
Close Jan 24 16:00 ET
  • 20.310
  • 0.0000.00%
Post 20:01 ET
1.77BMarket Cap-4.43P/E (TTM)

Travere Therapeutic Key Stats

Travere Therapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 68.147M--
--2024/Q4-- / 71.298M--
Oct 31, 20242024/Q362.898M / 60.831M--
Aug 1, 20242024/Q254.116M / 52.686M--
May 6, 20242024/Q141.374M / 43.616M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 68.147M--
--2024/Q4-- / 71.298M--
Oct 31, 20242024/Q362.898M / 60.831M--
Aug 1, 20242024/Q254.116M / 52.686M--
May 6, 20242024/Q141.374M / 43.616M--

Unlock Free Earnings Estimates

Travere Therapeutic Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 24, 2025

Strong Buy

  • Buy

    86.67%
  • Hold

    13.33%
  • Sell

    0.00%

Price Target

No Data